The history of Viagra presents a complex picture for investors. While the initial release generated massive profits, the end of its intellectual property protection opened the floodgates to generic alternatives, dramatically reducing revenue. This presents a unique challenge for firms banking on comparable blockbuster products, suggesting that a un

The history of Viagra, and its creator copyright, presents a intriguing case study for investors. Initially a blockbuster drug, generating billions in revenue , its patent expiration created a wave of generic competition , significantly eroding its dominance. While some pharmaceutical companies may try to capitalize on related treatments , the pres